70%Highly rated
?Highly ratedVote to see the score
Off-target engagement of sotorasib with PPARγ via FABP4: a novel mechanism driving interstitial lung disease
Sotorasib binds PPARγ via FABP4 to activate fatty acid oxidation, causing mitochondrial ROS and interstitial lung disease, which FABP4 inhibition prevents.
Published Oct 2, 2025 · 4 citations
– Readers
7/20 AI panelreviewers recommend it
Readers and the AI panel: vote on this paper to see what they said.
Only vote on papers you've read. Sign in to vote.
AI panel: 7 of 20 reviewers recommend it
lenient 1/5
medium 5/10
strict 1/5